Identification of mrnas differentially expressed in lymphocytes following interleukin-2 activation

Experimental Cell Research

Volumn 245, Issue 1, 1998, Pages 27-33

  Damiani, Giuseppe ^a   Capelli, Enrica ^a   Comincini, Sergio ^a   Mori, Elena ^a   Panelli, Simona ^a   Cuccia, Mariaclara ^a  

^a NONE

Author keywords

Cell activation; Differential display; Interleukin 2; Lymphocytes; MRNA

Indexed keywords

INTERLEUKIN 2; MESSENGER RNA;

ARTICLE; CELL COMMUNICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

MURINAE;

EID: 0031741186     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4230     Document Type: Article

References (30)

1. Abbas, A., Murphy, K. M., and Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature 383, 787-793.
2. Grimm, E. A., Mazumder, A., Zhang, H. Z., and Rosenberg, S. A. (1982). Lymphokine-activated killer cell phenomenon: Lysis of natural killer resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155, 1825-1841.
3. Janssen, R. A. J., Mulder, N. H., Hanw, T., and de Ley, L. (1994). The immunobiological effects of interleukin-2 in vivo. Cancer Immunol. Immunother. 39, 207-216.
4. Lafrernière, R., and Rosenberg, S. A. (1985). Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin-2 (IL-2) can mediate regression of both immunogenic and non-immunogenic sarcoma and adenocarcinoma. J. Immunol. 135, 4273-4280.
5. Mule, J. T., Sher, S., and Rosenberg, S. A. (1985). The antitumor efficacy of lymphokine activated killer cells and recombinant interleukin-2 in vivo. J. Immunol. 135, 464-450.
6. Ortaldo, J. R., Mason, A., and Overton, R. (1986). Lymphokine activated killer cells: Analysis of progenitors and effectors. J. Exp. Med. 164, 1193-1205.
7. Atzpodien, J., and Kirchner, H. (1990). Cancer cytokines and cytotoxic cells: Interleukin-2 in the immunotherapy of human neoplasms. Klin. Wochenschr 68, 1-11.
8. Lenardo, M. J. (1991). Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353, 858-861.
9. Capelli, E., Barni, S., Vaccarone, R., Fortis, C., and Nano, R. (1996). Cell activation and death (apoptosis) induced by IL-2: Ultrastructural evidence. Anticancer Res. 16, 1775-1780.
10. Nano, R., Barni, S., Capelli, E., Cremaschi, P., Catanese, C., Tomaselli, S., Nascimbene, C., and Prosperi, E. (1994). Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro. Acta Oncol. 33, 165-169.
11. Nano, R., Capelli, E., and Gerzeli, G. (1996). Morphofunctional characterization of lymphokine activated killer (LAK) cells. J. Biol. Res. 71, 181-187.
12. Welsh, J., Chada, K., Dalai, S. S., Cheng, R., Ralph, D., and McClelland, M. (1992). Arbitrarily primed PCR fingerprinting of RNA. Nucl. Acids Res. 20, 4965-4970.
13. McClelland, M., Mathieu-Daude, F., and Welsh, J. (1995). RNA fingerprinting and differential display using arbitrarily primed PCR. Trends Genet. 11, 242-246.
14. Liang, P., and Pardee, A. B. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971.
15. Chomczinski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 172, 156-159.
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Damiani, G., Telecco, S., Comincini, S., Sironi, M., Carretto, E., and Marone, P. (1996). Comparison of an improved RAPD fingerprinting with different typing methods for discriminating clinical isolates of staphylococcus spp. Eur. J. Epidemiol. 12, 163-169.
18. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., and Phillips, J. H. (1998). Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707.
19. Abrink, M., Aveskogh, M., and Hellman, L. (1995). Isolation of cDNA clones for 42 different Kruppel-related zinc finger proteins expressed in the human monoblast cell line U-937. DNA Cell Biol. 14, 125-136.
20. Maki, R. G., Old, L. J., and Srivastava, P. K. (1990). Human homologue of murine tumor rejection antigen gp96: 5′-regulatory and coding regions and relationship to stress induced proteins. Proc. Natl. Acad. Sci. USA 87, 5658-5652.
21. Altmeyer, A, Maki, R. G., Feldweg, A. M., Heike, M., Protopopov, V. P., Masur, S. K., and Srivastava, P. K. (1996). Tumor-specific cell surface expression of the KDEL containing endoplasmic reticular heat shock protein gp96. Int. J. Cancer 69, 340-349.
22. Li, Z., and Srivastava, P. K. (1993). Tumor rejection antigen gp96/grp94 is an ATPase: Implications for protein folding and antigen presentation. EMBO J. 12, 3143-3151.
23. Icho, T., Ikeda, T., Matsumoto, Y., Hanaoka, F., Kaji, K., and Tsuchida , N. (1994) A. novel human gene that is preferentially transcribed in heart muscle. Gene 144, 301-306.
24. Heike, M., Noll, B., and Meyer zum Buschenfelde, K. H. (1996). Heat shock protein-peptide complexes for use in vaccines. J. Leukoc. Biol. 60, 153-158.
25. De Leo, A. B., Becker, M., and Lu, L. W. (1993). Properties of a Mr 110.000 Tumor Rejection Antigen of the chemically induced BALB/c Meth A sarcoma. Cancer Res. 53, 1602-1607.
26. Smith K. A. (1988). Interleukin-2: Inception, impact and application. Science 240, 1169-1176.
27. Anderson, S. L., Shen, T., Lou, J., Xing, L., Blachere, N. E., Sirvastava, P. K., and Rubin, B. Y. (1994). The endoplasmic reticular heat shock protein gp96 is transcriptionally upregulated in interferon-treated cells. J.Exp. Med. 180, 1565-1569.
28. Dexter, T. M. (1994). Lymphokines. In "The Encyclopedia of Molecular Biology" (sir J. Kendrew, Ed.) pp. 592-596, Blackwell Sci. Oxford.
29. Karnitz, L. M., and Abraham, R. T. (1996). Interleukin-2 receptor signaling mechanisms. Adv. Immunol. 61, 147-199.
30. Ottaviani, E., Franchini, A., and Franceschi, C. (1997). Proopiomelanocortin-derived peptides, cytokines, and nitric oxide in immune responses and stress: An evolutionary approach. Int. Rev. of Cytology 170, 79-141.